Pfizer Inc. issued a press release providing an update on its guidance for full year 2023 and its performance in Q3 2023, as well as announcing a cost realignment program expected to deliver savings of at least $3.5 billion.
AI Assistant
PFIZER INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.